Literature DB >> 9113263

Antipyrine and aminopyrine induce acetaldehyde accumulation from ethanol in isolated hepatocytes.

M A Efthivoulou1, M N Berry.   

Abstract

The addition of antipyrine or aminopyrine to isolated hepatocytes derived from normal rats and incubated with ethanol caused a significant decrease in the oxidation of ethanol to acetate. This decrease was associated with a corresponding accumulation of acetaldehyde. The degree of inhibition with each drug was concentration-dependent, and there was a lag phase before inhibition of acetate formation and acetaldehyde accumulation became apparent. These effects were augmented in cells isolated from phenobarbital-treated rats, and the lag phase was reduced, implying that the effects of both drugs were dependent on their cytochrome P-450-mediated metabolism. The addition of the cytochrome P-450 inhibitor, cimetidine, significantly reduced the amount of acetaldehyde accumulating from ethanol when hepatocytes were incubated with either antipyrine or aminopyrine. Neither drug added directly to mitochondrial extracts inhibited the activity of aldehyde dehydrogenase. However, when neutralized extracts of hepatocytes that had undergone a 40-min incubation with ethanol and each drug were added to mitochondrial extracts, aldehyde dehydrogenase activity was substantially decreased. A greater inhibition was observed with neutralized extracts of hepatocytes from phenobarbital-treated rats. The results suggest that cytochrome P-450-generated metabolites of antipyrine and aminopyrine cause an inhibition of the low K(m) mitochondrial aldehyde dehydrogenase and thus an accumulation of acetaldehyde from ethanol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113263

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  1 in total

1.  The ethanol metabolite acetaldehyde inhibits the induction of long-term potentiation in the rat dentate gyrus in vivo.

Authors:  K Abe; S Yamaguchi; M Sugiura; H Saito
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.